Abstract. Lung functional impairment caused by acute pancreatitis (AP) is the primary contributor to AP-associated mortality. Previous studies have reported that AP-associated lung injury is associated with systemic inflammatory response syndrome and oxidative stress. In the present study, the protective effects of Danhong injection (DHI), a widely used Chinese Traditional Medicine preparation, on AP-associated lung injury in rats was examined. The myeloperoxidase activity, malondiadelhyde level and superoxide dismutase activity determination demonstrated the anti-inflammatory and anti-oxidative properties of DHI. The results of western blotting and reverse-transcription-semi-quantitative polymerase chain reaction indicated that DHI could protect rats against AP-associated lung injury, and the protective effect was associated with the suppression of nuclear factor-κB activation and cell adhesion molecule expression, and the reduction of neutrophil infiltration and oxidative stress levels. As demonstrated by HE staining, DHI inhibited the pancreas and lung tissue injury. Therefore, DHI could be a potential candidate for the treatment of patients with AP-associated lung injury.
Introduction
Acute pancreatitis (AP) is one of the most prominent emerging diseases in the world; 15% of cases are severe AP, with an associated mortality of ~10% (1) . Up to 20% of all mortalities induced by AP are associated with acute lung injury, which is the predominant cause of mortality within the first week of pancreatitis (2) . Previous studies indicated that AP-associated lung injury may be associated with systemic inflammatory response syndrome, including activation of neutrophils and macrophages and certain cytokines (3) (4) (5) . Furthermore, previous research has indicated that oxidative stress resulting from an imbalance between pro-oxidants and antioxidants also serves an important role in the pathogenesis of AP-associated lung injury (6) (7) (8) .
Danhong injection (DHI), a widely used Chinese Medicine preparation extracted from Salvia miltiorrhiza (Danshen in Chinese) and Carthamus tinctorius (Honghua in Chinese), had been used extensively in the clinic to treat cardiovascular diseases, such as coronary heart disease and cerebral ischemia (9) (10) (11) . The main components of DHI are danshensu, protocatechuic aldehyde, savianolic acid B, rosmarinic acid and hydroxysafflor yellow A (12) (13) (14) , and exerts anti-inflammatory, anti-oxidative and anti-fibrinolytic properties (10, 11, (15) (16) (17) (18) .
In the present study, the protective effects of DHI on AP-associated lung injury were evaluated. The effects of DHI on lung and pancreas pathological changes, malondiadelhyde (MDA) level, and myeloperoxidase (MPO) and superoxide dismutase (SOD) activities were investigated. Furthermore, the influences of DHI in the expression of nuclear factor (NF)-κB and cell adhesion molecules in lung tissues were examined. The results demonstrated the protective effects of DHI on AP-associated lung injury. The mechanism may be due to the suppression of NF-κB activation and cell adhesion molecule expression, and the reduction of neutrophil infiltration and oxidative stress levels. supplied by Laboratory Animal Center of Jiangxi University of Traditional Chinese Medicine (Nanchang, China). All rats were acclimated for 7 days prior to the experiment, housed in standard shoebox cages in a climate controlled environment with an ambient temperature of 23˚C and a 12-h light/dark cycle, and had free access to standard laboratory food and water. The rats were maintained under controlled environmental conditions and fasted for 24 h with free access to water prior to experiments. AP was induced with 3% sodium taurocholate by retrograde injection into the pancreatic duct as previously described (19) . Briefly, rats were anesthetized with intraperitoneal sodium pentobarbital (Sigma-Aldrich; Merck KGaA) at a dose of 50 mg/kg. The abdomen was opened by midline incision to allow manipulation of the duodenum and biliopancreatic duct. The common bile duct was occluded, and the duodenal wall was punctured on the antimesenteric side with a 24-gauge catheter. The catheter was advanced into the papilla vateri and fixed to the duodenal wall. For inducing AP, the catheter was brought near the pancreatic canal and 3% trichloroacetic acid (TCA, 0.1 ml/100 g; Sigma-Aldrich; Merck KGaA) was infused slowly using a pump according to the retrograde ductal injection model, followed by closure of the abdomen in two layers. The same procedure was applied to the sham-operated group, to which 0.9% NaCl was administered instead of TCA. No mortality was observed in the rats after AP was induced. All animals were randomly assigned to the three groups (n=20/group): i) Control (N), ii) AP and iii) DHI + AP (20 rats). Each group was randomly divided into two time-dependent subgroups (A, AP group 12 h; B, DHI + AP group 12 h; C, AP group 24 h; D, DHI + AP group 24 h) after the induction of AP. In the DHI + AP group, DHI was administered (8 ml/kg) intravenously 1 and 12 h after inducing AP, and the other groups was subjected to the same amount of normal saline.
Materials and methods

Chemical
Rats were sacrificed 12 or 24 h after the induction of AP, and the blood samples were obtained via the retro-orbital sinus using a 1.5 ml tube. After 30 min of standing, the serum was obtained by centrifugation (1,500 x g, 15 min, 4˚C) and 100 µl was used to measure serum amylase activity. The left upper lung tissues were dissected for determination of the wet/dry ratio immediately. The left lower lung tissues and head of pancreas were fixed in 4% paraformaldehyde for histopathologic analysis, and then the other portions of lung and pancreatic tissues were removed and stored at -70˚C until use.
Determination of the wet/dry ratio of lung.
After the mice were sacrificed, the left upper lung tissues (~1 g) were dissected, cleansed of blood with absorbent paper, weighed to obtain the 'wet' weight, torrefied in an 80˚C thermostatic baking oven for 48 h, and weighed again to obtain the 'dry' weight. Subsequently, the ratio of wet lung to dry lung was calculated to assess tissue edema.
Pathological analysis of lung and pancreas. For pathological analysis, the lung tissues and pancreas were processed by hematoxylin and eosin (HE) staining; ~4-µm thick sections were cut and then heat fixed, deparaffinized and rehydrated through a series of xylene and graded alcohols (100, 95, 85, 75%) and merged in distilled water. Section were stained with hematoxylin for 5 min, washed with water, and then stained with 0.5% eosin for 1-3 min at room temperature. After a further wash, the sections were sealed by neutral balsam. The specimens were examined under a light microscope, and scored by two blinded pathologists with expertise in lung and pancreatic pathology. The score of the pancreas and lung were determined using Schmidt's Method (20) and Tanino Method (21), respectively.
Amylase levels, MPO activity, MDA level and SOD activity determination of the lung and pancreas. MPO activity was used as a marker of neutrophil infiltration. In addition, the level of MDA is an index of membrane lipid peroxidation, and SOD activity is an index of superoxide toxicity. Lung and pancreas tissues were frozen in liquid nitrogen and then homogenized in PBS. The amylase levels in the tissue were detected by an Amylase Assay kit (Abnova, Taipei, Taiwan). The MPO activities in their homogenates were examined using a MPO determination kit. The remaining homogenates were centrifuged at 2,000 x g for 10 min at 4˚C, and the supernatants were used to detect the level of MDA and the SOD activity by using the MDA and SOD determination kits, respectively, according to the manufacturer's protocol.
Reverse-transcription-semi-quantitative polymerase chain reaction (RT-sqPCR).
Total RNA was extracted from rat lungs according using TRIzol reagent (Thermo Fisher Scientific, Inc., Waltham, MA, USA) (22) . Total RNA was reverse transcribed into cDNA using a ReverTraAce (Toyobo Life Science, Osaka, Japan). The mRNA expression levels of vascular cell adhesion protein 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), NF-κB p65 and β-actin were determined using a SYBR qPCR mix (Toyobo Life Science) and the ABI PRISM 7500 Sequence Detection system (Applied Biosystems; Thermo Fisher Scientific, Inc.), using the primer sequences listed in Table I . The PCR product was detected by 1.2% agarose gel electrophoresis, and the amount of PCR product was estimated by a gel imaging system (ChemiDoc XRS Image Lab™ software version 3.0, Bio-Rad Laboratories, Inc., Hercules, CA, USA). The intensity of VCAM-1, ICAM-1 and NF-κB was normalized against β-actin content.
Western blotting. Proteins were extracted from cells using lysis buffer containing 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 5 mM DTT, 1 mM EDTA, 0.1% SDS, 0.5% Triton X-100 and protease inhibitor cocktail tablets (Roche Applied Science, Penzberg, Germany). The proteins were separated by on 10% gels by SDS-PAGE. The quantity of protein loaded onto the gels was 50 µg, and proteins were then transferred onto polyvinylidene fluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were probed with antibodies specific for VCAM-1 (cat no. 14694), ICAM-1 (cat no. 4915) and NF-κB p65 (cat no. 8242) (Cell Signaling Technology, Inc., Danvers, MA, USA) at a dilution of 1:1,000 and β-actin (cat no. sc-47778, Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at a dilution of 1:2,000 with PBST, overnight at 4˚C. Finally, the membrane was incubated with a horseradish peroxidase conjugated secondary mouse antibody or antibody rabbit (cat nos. sc-2314 or sc-2313, Santa Cruz Biotechnology, Inc.) for 1 h at room temperature. Immunocomplexes were visualized with an enhanced chemiluminescence system (Thermo Fisher Scientific, Inc.). ImageJ software version 3.0 (National Institutes of Health, Bethesda, MD, USA) was used to compare the density of bands on the blots. Statistical analysis. The data were analyzed by SPSS 18.0 (SPSS, Inc., Chicago, IL, USA). The results are expressed as the mean ± standard error. The statistical significance was evaluated by one-way analysis of variance followed by Student-Newmane-Keuls test. P<0.05 was considered to indicate a statistically significant difference.
Results
Histological examination of the effects of DHI on pancreatic and lung injury in AP.
The model of AP was induced by infusion of 5% sodium taurocholate (1 ml/kg). Compared with control rats (Fig. 1A) , AP rats pancreas had significant morphological changes in the pancreas (Fig. 1B) . Furthermore, an extensive infiltration of leukocytes into the pancreas, beside of tissue edema, blood vessel dilatation, and congestion vessel could be seen in the pancreas (Fig. 1B) . Compared with the AP group, a significant reduction of acinar necrosis, edema, and inflammatory infiltration were observed in the DHI + AP group (Fig. 1C) . No evident histological alteration was observed in the lung of control mice (Fig. 1D) . AP resulted in significant lung injury, evidenced by presence of interstitial edema, alveolar thickening and extensive recruitment of neutrophils into the alveolar spaces (Fig. 1E ). These pathological changes were improved by DHI administration (Fig. 1F) . In both the lung ( Fig. 2A ) and the pancreas (Fig. 2B) , AP significantly increased the histopathologic damage score; however, DHI treatment reduced this score. Therefore, DHI may prevent the pancreatic injury in AP.
MPO activity, MDA levels and SOD activity in the pancreas in AP following DHI treatment. MPO activity, a marker of neutrophil function, is used for assessing the intensity of inflammation (23) . In addition to increased plasma amylase levels (Fig. 3A) , MPO activity (Fig. 3B ) and MDA levels ( Fig. 4A) were significantly enhanced in the AP group and markedly ameliorated by DHI. However, SOD activity was reduced by AP, but DHI significantly reversed this effect (Fig. 4B) . These results suggested that DHI may reduce pancreatic inflammation.
Effect of DHI on lung wet/dry ratio in AP.
Compared with the control group, the lung wet/dry ratio in the AP group increased significantly, whereas it was significantly attenuated in the DHI + AP group (Fig. 5A) . Therefore, DHI could suppress AP-induced lung edema.
MPO activity, MDA levels and SOD activity in the lung in AP following DHI treatment. The role of DHI on MPO activity, MDA content and SOD activity in lung tissues were investigated. A significant rise in lung MPO activity (Fig. 5B ) and MDA level (Fig. 6A) , and a decrease in lung SOD activity (Fig. 6B) were observed in the AP group, indicating neutrophil infiltration, membrane lipid peroxidation and superoxide toxicity in lung tissue as a result of AP, respectively. Treatment with DHI ameliorated this effect.
mRNA and protein expression level alterations in the lung in AP following DHI treatment. In order to gain understanding into the action of DHI on AP-associated lung injury at the molecular level, the effects of DHI on the mRNA and protein expression levels of VCAM-1, ICAM-1 and NF-κB p65 were assessed by RT-sqPCR and western blotting, respectively. AP rats exhibited significantly increased mRNA expression levels of NF-κB p65 (Fig. 7A) , VCAM-1 (Fig. 7B ) and ICAM-1 (Fig. 7C) . The same effect was observed from RT-sqPCR (Fig. 7D) . However, treatment with DHI significantly reversed this effect. Representative western blot images are presented in Fig. 7E .
Discussion
DHI, a popular herbal medicine in China, consists of Salvia miltiorrhiza and Carthamus tinctorius. As described previously, DHI has served a positive role on scavenging oxygen free radicals, preventing lipid peroxide, inhibiting inflammatory reaction and improving microcirculation. Furthermore, inflammatory release and the oxygen reaction serve an important role in the pathogenesis of AP-associated multi-organ complications. Therefore, the present study investigated the protective effect of DHI on AP-associated lung injury.
NF-κB is as a transcription factor which regulates various genes involved in inflammatory and immune responses (24) . Current research has focused on the association between NF-κB and AP (25) . NF-κB modulates the expression of numerous genes, such as genes encoding for cytokines, adhesion molecules and enzymes, which serves a pivotal role in the initiation, promotion and progression of the inflammatory response (26) . In turn, AP could upregulate NF-κB expression, exacerbating inflammation to AP (27, 28) . In the present study, in the AP group, NF-κB p65 was markedly increased, and the mRNA and protein expression levels of adhesion factors (VCAM-1 and ICAM-1) were increased. After animals were treated with DHI, the activation of NF-κB p65 was significantly inhibited, and the expression of VCAM-1 and ICAM-1 were markedly decreased. These results demonstrated that DHI could inhibit NF-κB p65 activation, modulate the expression of VCAM-1 and ICAM-1, and suppress the inflammatory response in AP.
Oxidative stress had been demonstrated to serve a key role in causing tissue damage in AP. Abnormal generation of reactive oxygen species occurs during the course of pancreatitis, leading to pancreatic oxidative stress and even systemic oxidative stress (29, 30 ). Furthermore, the MDA level, an important index of oxidative stress, could increase expression of NF-κB (31) . In the present study, a significant rise of MDA level was observed in the AP group, whereas this was decreased in the DHI + AP group. In addition, the activity of SOD, an endogenous free radical scavenging agent which can eliminate oxyradicals, was also examined. AP decreased SOD activity in pancreas and lung tissue, while SOD activities increased in mice treated with DHI, compared with those in the AP group. These results indicated the DHI could effectively attenuate oxidative stress injury in AP-associated lung injury.
In conclusion, the present study demonstrated the protective and therapeutic effects of DHI on AP-associated lung injury by suppressing the NF-κB activity, decreasing neutrophil infiltration and the oxidative stress level, and reducing the expression levels endodermis attachment proteins (VCAM-1 and ICAM-1). Therefore, DHI may represent a potential candidate for therapy of AP. 
